Choksi Laboratories schedules board meeting on May 25, 2026 to approve standalone audited financial results for Q4 and FY ended March 31, 2026.
Meeting will be held at company's registered office in Indore with potential additional agenda items subject to chairman and director approval.
Trading window for securities will reopen 48 hours after declaration of audited financial results for all designated persons and connected individuals.